Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-025641
Filing Date
2025-05-14
Accepted
2025-05-14 19:51:14
Documents
1
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747266667.html 4  
1 FORM 4 wk-form4_1747266667.xml 4 5605
  Complete submission text file 0001628280-25-025641.txt   7063
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Parsey Merdad (Reporting) CIK: 0001792150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 25947929